Cue Biopharma Insider Trades
NASDAQ: CUEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 5 · $99.75K
- Sales
- 15 · $2.43M
- Shares bought / sold
- 323.86K / 86.79K
- Net activity
- Net selling $2.3 million
Cue Biopharma insider activity
Over the last 12 months, Cue Biopharma insiders reported 35 transactions on SEC Form 4: 5 open-market purchases and 15 sales. Insiders bought $99,747 and sold $2.4 million worth of stock, for net insider selling of $2.3 million. The largest seller was Lin Shao-Lee, with $1.9 million in reported sales.
The most recent filing shows Meluzio Michael Vincent (VP, Prin. Accounting Officer) selling 1,144 shares at $28.05 on Oct 12, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CUE's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
CUE insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 12, 2026 | Lin Shao-LeeChief Executive Officer | Sale | 1,087 | $30.49K | Form 4 |
| Oct 12, 2026 | Lin Shao-LeeChief Executive Officer | Sale | 10,000 | $275.00K | Form 4 |
| Oct 12, 2026 | Ray SumitaChief Legal Compliance Officer | Sale | 1,844 | $51.72K | Form 4 |
| Oct 12, 2026 | Meluzio Michael VincentVP, Prin. Accounting Officer | Sale | 1,144 | $32.09K | Form 4 |
| Aug 13, 2026 | Lin Shao-LeeChief Executive Officer | Sale | 10,460 | $308.36K | Form 4 |
| Aug 13, 2026 | Lin Shao-LeeChief Executive Officer | Sale | 2,375 | $66.76K | Form 4 |
| Aug 13, 2026 | Lin Shao-LeeChief Executive Officer | Sale | 5,423 | $147.45K | Form 4 |
| Aug 13, 2026 | Meluzio Michael VincentVP, Prin. Accounting Officer | Sale | 3 | $93.39 | Form 4 |
| Aug 13, 2026 | Meluzio Michael VincentVP, Prin. Accounting Officer | Sale | 4,106 | $124.62K | Form 4 |
| Aug 13, 2026 | Meluzio Michael VincentVP, Prin. Accounting Officer | Sale | 1,519 | $44.61K | Form 4 |
| Aug 13, 2026 | Meluzio Michael VincentVP, Prin. Accounting Officer | Option exercise | 13,647 | — | Form 4 |
| Aug 13, 2026 | Ray SumitaChief Legal Compliance Officer | Sale | 4 | $124.52 | Form 4 |
| Aug 13, 2026 | Ray SumitaChief Legal Compliance Officer | Sale | 6,442 | $195.51K | Form 4 |
| Aug 13, 2026 | Ray SumitaChief Legal Compliance Officer | Sale | 2,383 | $69.99K | Form 4 |
| Aug 13, 2026 | Ray SumitaChief Legal Compliance Officer | Option exercise | 18,196 | — | Form 4 |
| Aug 12, 2026 | Lin Shao-LeeChief Executive Officer | Sale | 5,775 | $160.26K | Form 4 |
| Aug 12, 2026 | Lin Shao-LeeChief Executive Officer | Sale | 34,225 | $923.73K | Form 4 |
| Aug 12, 2026 | Lin Shao-LeeChief Executive Officer | Option exercise | 109,179 | — | Form 4 |
| Jul 30, 2026 | Ahlers James MChief Financial Officer | Award | 25,500 | — | Form 4 |
| Jul 13, 2026 | Borie Dominique ChristianChief Medical Officer | Award | 31,500 | — | Form 4 |
| Jul 9, 2026 | Lin Shao-LeeChief Executive Officer | Award | 327,537 | — | Form 4 |
| Jul 9, 2026 | Meluzio Michael VincentVP, Prin. Accounting Officer | Award | 40,942 | — | Form 4 |
| Jul 9, 2026 | Sarraf PashaDirector | Award | 21,800 | — | Form 4 |
| Jul 9, 2026 | Garzone PamelaDirector | Award | 21,800 | — | Form 4 |
| Jul 9, 2026 | Ray SumitaChief Legal Compliance Officer | Award | 54,589 | — | Form 4 |
| Jul 9, 2026 | Meehan Viola MongDirector | Award | 21,800 | — | Form 4 |
| Jul 9, 2026 | Camardo Daniel A.Director | Award | 21,800 | — | Form 4 |
| Jul 9, 2026 | Garzone PamelaDirector | Award | 18,900 | — | Form 4 |
| Jul 9, 2026 | Sarraf PashaDirector | Award | 18,400 | — | Form 4 |
| May 3, 2026 | Lin Shao-LeeCHIEF EXECUTIVE OFFICER | Award | 327,537 | — | Form 4 |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 77,417 | $23.35K | Form 4 |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 78,116 | $24.33K | Form 4 |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 86,947 | $27.60K | Form 4 |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 77,148 | $23.17K | Form 4 |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 4,229 | $1.31K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4